Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds

Gut

Volumn 35, Issue 4, 1994, Pages 455-460

  Verdu, E ^a   Viani, F ^a   Armstrong, D ^a   Fraser, R ^a   Siegrist, H H ^a   Pignatelli, B ^b   Idstrom J P ^c   Cederberg, C ^c   Blum, A L ^a   Fried, M ^a,d  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c ASTRAZENECA R AND D   (Sweden)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NITRATE; NITRITE; NITROSO DERIVATIVE; OMEPRAZOLE; PLACEBO;

ADULT; ARTICLE; BACTERIAL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH; STOMACH ACID SECRETION; STOMACH ULCER;

EID: 0028343722     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.35.4.455     Document Type: Article

References (45)

1. Hetzel DJ, Dent J, Reed WD, Narievala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903-12.
2. 2 receptor antagonists. Scand J Gastroenterol 1989; 24 (suppl 166): 88-93.
3. Brunner G, Creutzfeldt W. Omeprazole in the long-term treatment of patients with acid-related diseases resistant to ranitidine. Scand J Gastroenterol 1989; 24 (suppl 166): 101-5.
4. Lundell L. Prevention of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Digestion 1990; 47 (suppl 1): 72-5.
5. 2-blocker-resistant oesophagitis. Dig Dis Sci 1991; 36: 552-7.
6. Wormsley KG. Assessing the safety of drugs for the long-term treatment of peptic ulcers. Gut 1984; 25: 1416-23.
7. Festen HPM. Profound gastric acid inhibition. Advantages and potential hazards, Scand J Gastroenterol 1989; 24 (suppl 171): 99-105.
8. Stern WR. Summary of the 34th meeting of the food and drug administration gastrointestinal drugs advisory committee March 15 and 16 1989. Am J Gastroenterology 1989; 84: 1351-5.
9. Colin-Jones DG. Acid suppression: how much is needed? Adjust it to suit the condition. BMJ 1990; 301: 564-5.
10. Husebye E, Skar V, Hoverstad T, Melby K. Fasting hypochlorhydria with Gram positive flora is highly prevalent in healthy old people. Gut 1992; 33: 1331-7.
11. Snepar R, Poporad GA, Romano R, Kobasa WD, Kaye D. Effect of cimetidine and antacid on gastric microbial flora. Infect Immun 1982; 36: 518-24.
12. Du Moulin GC, Paterson DG, Hedley-Whyte J, Lisbon J. Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway. Lancet 1982; i: 242-5.
13. Ruddell WSJ, Axon ATR, Findlay JM, Bartholomew BA, Hill MJ. Effect of cimetidine on the gastric bacterial flora. Lancet 1980; i: 672-4.
14. Milton-Thompson GJ, Lightfoot NF, Ahmet Z, Hunt RH, Barnard J, Bavin PMG, et al. Intragastric acidity, bacteria, nirite, and N-nitroso compounds before, during, and after cimetidine treatment. Lancet 1982; i: 1091-5.
15. Meyrick Thomas J, Misiewicz JJ, Cook AR, Hill MJ, Smith PLR, Walters CL, et al. Effect of one year's treatment with ranitidine and of truncal vagotomy on gastric contents. Gut 1987; 28: 726-38.
16. Allan Gray JD, Shiner M. Influence of gastric pH on gastric and jejunal flora. Gut 1967; 8: 574-81.
17. Hall CN, Darkin D, Brimblecombe R, Cook AJ, Kirkham JS, Northfield TC. Evaluation of the nirtosamine hypothesis of gastric carcinogenesis in pecancerous conditions. Gut 1986; 27: 491-8.
18. Northfield TC, Hall CN. Carcinoma of the gastric stump: risks and pathogenesis. Gut 1990; 31: 1217-9.
19. Sharma BK, Santana IA, Wood EC, Walt RP, Peraire M, Noone P, et al. Intragastric bacterial activity and nitrosation before, during and after treatment with omeprazole. BMJ 1984; 289: 717-9.
20. Watt PCH, Sloan JM, Donaldson JD, Patterson CC, Kennedy TL. Relationship between histology and gastric juice pH and nitrite in the stomach after operation for duodenal ulcer. Gut 1984; 25: 246-52.
21. Wormsley KG. Intragastric bacterial activity and nitrosation before, during and after treatment with omeprazole [Letter]. BMJ 1984; 289: 1007.
22. Pignatelli B, Malaveille C, Chen CS, Ohshima H, Hautefeuille A, Thuillier P, et al. N-nitroso compounds (NOC), genotoxins and their precursors in gastric juice (GJ) from humans with or without precancerous lesions of the stomach. In: O'Neill IK, Chen J, Bartsch H, eds. Relevance to human cancer of N-nitroso compounds, tobacco smoke and mycotoxins. Lyon: IARC Scientific Publications No 105. International Agency for Research on Cancer, 1991: 172-7.
23. Pignatelli B, Richard I, Bourgade MC, Bartsch H. Improved group determination of total N-nitroso compounds (NOC) in human gastric juice by denitrosation and thermal energy analysis. Analyst 1987; 112: 945-9.
24. Bardhan PK, Gyr K, Beglinger C, Vogtlin J, Frey R, Vischer W. Diagnosis of bacterial overgrowth after culturing proximal small bowel aspirate obtained during routine upper gastrointestinal endoscopy. Scand J Gastroenterol 1992; 27: 253-6.
25. 14C-urea breath test. Scand J Gastroenterol 1989; 24 (suppl 160): 25-6.
26. Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Schandomy H, eds. Manual of clinical microbiology. 5th Ed. Washington DC: American Society of Microbiology, 1991.
27. 15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131-8.
28. Malawer SJ, Powell DW. An improved turbidimetric analysis of polyethylene glycol utilizing an emulsifier. Gastronterology 1967; 53: 250-6.
29. Streithberg B, Rohmel J. Exakte Verteilungen fur Rang- und Randomisierungstests im allgemeinen c-Stichproben-problem. EDV in Medizin und Biologie 1987; 18: 12-9.
30. Tannenbaum SR. Ni-nitroso compounds: a perspective on human exposure. Lancet 1983; i: 629-31.
31. Reed PI, Smith PLR, Haines K, House FR, Walters CL. Effect of cimetidine on gastric juice N-nitrosamine concentration. Lancet 1981; ii: 553-6.
32. Lijinsky W. Nitrosamines and nitrosamides in the aetiology of gastrointestinal cancer. Cancer 1977; 40: 2446-9.
33. Reed PI, Smith PLR, Haines K, House FR, Walters CL. Gastric juice N-nitrosamines in health and gastroduodenal disease. Lancet 1981; ii: 550-2.
34. Watt PCH, Patterson CC, Kennedy TL. Late mortality after vagotomy and drainage for duodenal ulcer. BMJ 1984; 288: 1335-8.
35. Viste A, Bjornestad E, Opheim P, Skarstein A, Thunold J, Hartveit F, et al. Risk of carcinoma following gastric operations for benign disease. A historical cohort study of 3470 patients. Lancet 1986; ii: 502-5.
36. Ross AHM, Smith MA, Anderson JR, Small WP. Late mortality after surgery for peptic ulcer. N Engl J Med 1982; 307: 519-22.
37. Caygill CPJ, Hill MJ, Hall CH, Kirkham JS, Northfield TC. Increased risk of cancer at multiple sites after gastric surgery for peptic ulcer. Gut 1987; 28: 924-8.
38. Schlag P, Bockler R, Peter M, Herfarth Ch. Nitrite and N-nitroso compounds in the operated stomach. Scand J Gastroenterol 1981; 16 (suppl 67): 63-9.
39. Calmels S, Oshima H, Vincent P, Gounot AM, Bartsch H. Screening of microorganisms for nitrosation catalysis at pH 7 and kinetic studies on nitrosamine formation from secondary amines by E coli strains. Carcinogenesis 1985; 6: 911-5.
40. Leach S, Thompson M, Hill M. Bacterially catalysed N-nitrosation in the human stomach. Carcinogenesis 1987; 8: 1907-12.
41. Sharma BK, Walt RP, Pounder RE, Gomes M de FA, Wood EC, et al. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut 1983; 25: 957-64.
42. Bell NJ, Rohss K, Cederberg C, Hunt RH. Does tachyphylaxis and/or rebound acid secretion occur during/after treatment with omeprazole or ranitidine. Gastroenterology 1993; 104: A41.
43. Cederberg C. Clinical pharmacology of intravenous omeprazole. Experimental studies in healthy subjects and duodenal ulcer patients [Thesis]. Goteburg: University of Goteborg, 1992: 1-19.
44. Walt RP, Gomes M de FA, Wood EC, Logan LH, Pounder RE. Effect of oral omeprazole on 24 hour intragastric acidity. BMJ 1983; 287: 12-4.
45. Armstrong D, Verdu E, Fraser R, Viani F, Idström J-P, Cederberg C, et al. Helicobacter pylori infection augments the antisecretory effect of omeprazole. [Abstract]. Acta Gastroenterol Belg 1993; 56: 129.